Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 586 to 600 of 1290 results for position

  1. What are the challenges and potential solutions for UK employers and employees in micro-, small- and medium-sized organisations (which may not have easy access to additional services such as employee assistance programmes or occupational health services) in ensuring sickness policy is managed effectively and facilitating return to work?

    whereas micro-, small- and medium-sized organisations may not be in a position to fund external occupational health provision or...

    Research recommendation
    Published
    10 February 2020

  2. About quality standards

    Our quality standards set out priority areas for quality improvement in health, public health and social care.

  3. Adapting NICE guidelines

    Our experts can offer advice and support in contextualising our guidelines, or helping you adapt our content to your country or local context.

  4. Getting involved as someone with lived experience

    We want you to help NICE to develop our guidance for NHS and care services.

  5. Step-by-step guide to registering as a stakeholder

    How to register as a stakeholder with NICE.

  6. Commercial access agreements

    The NICE commercial liaison team aim to reduce the workload for the NHS and frontline staff by making commercial agreements more straightforward.

  7. Step-by-step guide to registering as a stakeholder

    How to register as a stakeholder with NICE.

  8. Getting involved as someone with lived experience

    We want you to help NICE to develop our guidance for NHS and care services.

  9. How our guidance and standards can help you

    NICE guidance and standards support health professionals by providing evidence-based recommendations that enhance clinical decision-making and patient care.

  10. Cost saving, resource planning and audit

    NICE's guidance and advice can help you make the best use of resources and generate cost savings.

  11. Use of our content internationally

    Using our content internationally. Includes information on fees and licensing agreements for both AI and non AI requests.

  12. Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy (TA374)

    Evidence-based recommendations on erlotinib (Tarceva) and gefitinib (Iressa) for treating non-small-cell lung cancer after chemotherapy in adults.

    Technology appraisal guidance
    Published
    16 December 2015
    View recommendations

    Sections for TA374

  13. Taking a proportionate approach to technology appraisals

    Learn about NICE's proportionate approach to technology appraisals, which aims to streamline the evaluation process for new health technologies, ensuring timely access to innovative treatments while maintaining rigorous standards.

  14. Stage 5: discharge and transferring care

    Our guidance helps you hand over care and ensure people are safely transitioned out of the virtual ward environment.

  15. Key question: caring

    This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.